Total Payments
$1,850
2021 Payments
$31.96
Companies
9
Transactions
55
Medicare Patients
5,093
Medicare Billing
$667,389
Payment Breakdown by Category
Food & Beverage$1,845 (99.7%)
Education$5.00 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,845 | 54 | 99.7% |
| Education | $5.00 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,280 | 34 | $0 (2020) |
| Novo Nordisk Inc | $137.71 | 8 | $0 (2020) |
| Lilly USA, LLC | $106.44 | 3 | $0 (2021) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $99.34 | 1 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $87.75 | 2 | $0 (2019) |
| Amarin Pharma Inc. | $37.14 | 2 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $34.85 | 2 | $0 (2019) |
| Vanda Pharmaceuticals Inc. | $33.24 | 1 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $32.98 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $31.96 | 2 | Lilly USA, LLC ($19.65) |
| 2020 | $352.41 | 12 | AstraZeneca Pharmaceuticals LP ($253.45) |
| 2019 | $502.70 | 15 | AstraZeneca Pharmaceuticals LP ($229.64) |
| 2018 | $337.16 | 13 | AstraZeneca Pharmaceuticals LP ($284.87) |
| 2017 | $625.69 | 13 | AstraZeneca Pharmaceuticals LP ($512.51) |
All Payment Transactions
55 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/17/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $12.31 | General |
| Category: Cardiovascular | ||||||
| 06/17/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Diabetes | ||||||
| 11/09/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/15/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Diabetes | ||||||
| 09/21/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Diabetes | ||||||
| 07/15/2020 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: Diabetes | ||||||
| 06/25/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/12/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: Cardiovascular | ||||||
| 06/04/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/13/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/17/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/05/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Endocrinology | ||||||
| 02/14/2020 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/16/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $117.44 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/08/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/03/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $73.91 | General |
| 09/27/2019 | Vanda Pharmaceuticals Inc. | Hetlioz (Drug) | Food and Beverage | In-kind items and services | $33.24 | General |
| Category: Non-24-Hour Sleep-Wake Disorder | ||||||
| 09/13/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, ASMANEX | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/28/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $133.16 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/19/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Diabetes | ||||||
| 06/29/2019 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug), FARXIGA | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/28/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/11/2019 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $75.47 | General |
| Category: Diabetes | ||||||
| 06/11/2019 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.32 | General |
| Category: Diabetes | ||||||
| 05/03/2019 | Novo Nordisk Inc | Tresiba (Drug), Victoza | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,171 | 1,699 | $254,094 | $134,108 |
| 2022 | 10 | 3,540 | 5,392 | $862,357 | $508,471 |
| 2021 | 7 | 293 | 393 | $52,606 | $17,510 |
| 2020 | 4 | 89 | 120 | $20,377 | $7,300 |
Total Patients
5,093
Total Services
7,604
Medicare Billing
$667,389
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 0001A | Adm sarscov2 30mcg/0.3ml 1st | Office | 2021 | 57 | 57 | $1,989 | $1,089 | 54.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 35 | 38 | $228.00 | $114.00 | 50.0% |
| 91300 | Sarscov2 vac 30mcg/0.3ml im | Office | 2021 | 31 | 31 | $0.31 | $0.31 | 100.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 36 | 56 | $9,840 | $2,607 | 26.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 28 | 35 | $5,970 | $2,279 | 38.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 14 | 14 | $3,647 | $1,795 | 49.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 11 | 15 | $920.00 | $620.16 | 67.4% |
About Dr. Joselito Babaran, MD
Dr. Joselito Babaran, MD is a Internal Medicine healthcare provider based in Panorama City, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1225072564.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joselito Babaran, MD has received a total of $1,850 in payments from pharmaceutical and medical device companies, with $31.96 received in 2021. These payments were reported across 55 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($1,845).
As a Medicare-enrolled provider, Babaran has provided services to 5,093 Medicare beneficiaries, totaling 7,604 services with total Medicare billing of $667,389. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Panorama City, CA
- Active Since 06/16/2006
- Last Updated 08/08/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1225072564
Products in Payments
- FARXIGA (Drug) $971.63
- BYDUREON (Drug) $180.12
- JARDIANCE (Drug) $86.79
- SYMBICORT (Drug) $68.33
- BEVESPI AEROSPHERE (Drug) $60.39
- Ozempic (Drug) $52.82
- Tresiba (Drug) $39.38
- Vascepa (Drug) $37.14
- JANUVIA (Drug) $34.85
- Hetlioz (Drug) $33.24
- Victoza (Drug) $22.77
- RYBELSUS (Drug) $22.74
- TRULICITY (Drug) $19.65
- SOLIQUA 100/33 (Biological) $18.87
- TOUJEO (Drug) $14.11
- TRADJENTA (Drug) $13.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Panorama City
Dr. Shehnaz Habib, M.d, M.D
Internal Medicine — Payments: $9,542
Internal Medicine $9,542
Hermilito Villar
Internal Medicine — Payments: $3,753
Internal Medicine $3,753
Erica Chen, M.d, M.D
Internal Medicine — Payments: $3,561
Internal Medicine $3,561
Dr. Kevin Wu, Md, MD
Internal Medicine — Payments: $3,250
Internal Medicine $3,250
Jacob Schwartz, Pa-C, PA-C
Internal Medicine — Payments: $2,627
Internal Medicine $2,627
Lynnette Tatosyan, Md, MD
Internal Medicine — Payments: $1,384
Internal Medicine $1,384